- Type / Class
- Equity / Common Stock
- Shares outstanding
- 4,518,092
- Total 13F shares
- 31,809,122
- Share change
- -771,337
- Total reported value
- $90,667,261
- Put/Call ratio
- 100%
- Price per share
- $2.85
- Number of holders
- 99
- Value change
- -$2,740,786
- Number of buys
- 59
- Number of sells
- 35
Quarterly Holders Quick Answers
What is CUSIP 416906105?
CUSIP 416906105 identifies HBIO - HARVARD BIOSCIENCE INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 416906105:
Top shareholders of HBIO - HARVARD BIOSCIENCE INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| 272 Capital LP |
13F
|
Company |
63%
|
2,834,941
|
$12,020,150 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
63%
|
2,833,664
|
$12,014,736 | — | 31 Mar 2024 | |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. |
13F
|
Company |
61%
|
2,772,339
|
$11,754,717 | — | 31 Mar 2024 | |
| Harvey Partners, LLC |
13F
|
Company |
57%
|
2,557,500
|
$10,843,800 | — | 31 Mar 2024 | |
| AMH Equity Ltd |
13F
|
Company |
51%
|
2,324,200
|
$9,854,608 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
48%
|
2,152,147
|
$9,125,104 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
43%
|
1,926,326
|
$8,167,623 | — | 31 Mar 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
41%
|
1,863,750
|
$7,902,300 | — | 31 Mar 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
30%
|
1,348,779
|
$5,718,823 | — | 31 Mar 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
30%
|
1,344,308
|
$5,699,866 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
22%
|
1,004,097
|
$4,255,000 | — | 31 Mar 2024 | |
| HEARTLAND ADVISORS INC |
13F
|
Company |
20%
|
889,133
|
$3,769,924 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
19%
|
856,224
|
$3,630,818 | — | 31 Mar 2024 | |
| Meros Investment Management, LP |
13F
|
Company |
18%
|
821,792
|
$3,484,398 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
16%
|
702,478
|
$2,979,000 | — | 31 Mar 2024 | |
| Portolan Capital Management, LLC |
13F
|
Company |
15%
|
697,840
|
$2,958,842 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
15%
|
693,229
|
$2,939,291 | — | 31 Mar 2024 | |
| Bertrand Loy |
3/4/5
|
Director |
—
class O/S missing
|
556,208
|
$2,286,015 | — | 21 May 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
10%
|
456,097
|
$1,933,851 | — | 31 Mar 2024 | |
| Michael A. Rossi |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
260,540
|
$1,393,889 | — | 29 Dec 2022 | |
| Acuitas Investments, LLC |
13F
|
Company |
7.2%
|
326,516
|
$1,384,428 | — | 31 Mar 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
7.1%
|
321,523
|
$1,363,258 | — | 31 Mar 2024 | |
| BARD ASSOCIATES INC |
13F
|
Company |
6.4%
|
291,320
|
$1,235,197 | — | 31 Mar 2024 | |
| Thomas W. Loewald |
3/4/5
|
Director |
—
class O/S missing
|
295,311
|
$1,213,728 | — | 21 May 2024 | |
| Alan I. Edrick |
3/4/5
|
Director |
—
class O/S missing
|
273,911
|
$1,125,774 | — | 21 May 2024 | |
| Archon Capital Management LLC |
13F
|
Company |
5.8%
|
260,858
|
$1,106,038 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
5.4%
|
243,130
|
$1,030,871 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
5.1%
|
229,779
|
$974,263 | — | 31 Mar 2024 | |
| GREENWOOD CAPITAL ASSOCIATES LLC |
13F
|
Company |
4.8%
|
216,614
|
$918,443 | — | 31 Mar 2024 | |
| Kenneth Fletcher Olson |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
155,595
|
$832,433 | — | 29 Dec 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.1%
|
184,500
|
$782,280 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
3.9%
|
178,350
|
$756,204 | — | 31 Mar 2024 | |
| Pasadena Private Wealth, LLC |
13F
|
Company |
3.8%
|
172,485
|
$731,336 | — | 31 Mar 2024 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
3.3%
|
147,802
|
$626,680 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
3.2%
|
144,055
|
$610,793 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
3.1%
|
139,999
|
$593,596 | — | 31 Mar 2024 | |
| STRS OHIO |
13F
|
Company |
2.5%
|
115,200
|
$488,000 | — | 31 Mar 2024 | |
| ClariVest Asset Management LLC |
13F
|
Company |
2.5%
|
111,039
|
$470,805 | — | 31 Mar 2024 | |
| Riverwater Partners LLC |
13F
|
Company |
2.1%
|
93,197
|
$395,155 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
2%
|
88,156
|
$373,781 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.8%
|
80,015
|
$339,264 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.7%
|
77,483
|
$328,528 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
1.7%
|
75,970
|
$322,113 | — | 31 Mar 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
1.6%
|
72,860
|
$308,926 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.4%
|
64,576
|
$273,802 | — | 31 Mar 2024 | |
| WINTON GROUP Ltd |
13F
|
Company |
1.4%
|
64,041
|
$271,534 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
57,329
|
$243,075 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.93%
|
41,981
|
$177,999 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.9%
|
40,729
|
$172,692 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.88%
|
39,930
|
$169,303 | — | 31 Mar 2024 |
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2024
As of 30 Jun 2024,
HARVARD BIOSCIENCE INC - Common Stock (HBIO) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,809,122 shares.
The largest 10 holders included
BlackRock Inc., PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., Harvey Partners, LLC, AMH Equity Ltd, VANGUARD GROUP INC, Granahan Investment Management, LLC, DIMENSIONAL FUND ADVISORS LP, 272 Capital LP, ROYCE & ASSOCIATES LP, and BOOTHBAY FUND MANAGEMENT, LLC.
This page lists
99
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
88
Q2 2024 holders
99
Holder diff
11
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.